Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

As CVS Plans Merger With Aetna, What Will It Mean For U.S. Hospitals?

December 5, 2017 By Daniel Seeger

The weekend announcement that CVS Health planned to purchase Aetna has recast healthcare industry observers as amateur fortune tellers, trying desperately to determine what the $69 billion deal will mean for doctors and patients.

Representatives for both the pharmacy chain and the insurance giant are of course touting expected efficiencies, which they say will lead to lower costs and greater customer convenience. Others are more skeptical.

“They’re not doing this to provide better care to people,” David Mitchell, founder of the advocacy group Patients for Affordable Drugs, told The New York Times. “They’re doing this to make more money.”

CVS and Aetna plan to share information and resources to shift the corner drugstore to a more all-encompassing provider of healthcare services. In additional to filling prescriptions, company executives envision a group of providers on site that can do basic lab work, consult on ongoing medical concerns, and address the sort of flaring ailments that now might send patients to their primary care doctor or even to the emergency room.

“We think of it as creating a new front door to healthcare in America,” Larry J. Merlo, president and CEO of CVS Health, enthused.

While the merging of these two massive entities in the healthcare field is broadly seen as a bulwark against the rumored entry of online retailer Amazon into the pharmacy business, another part of the sector could face a graver and more immediate threat from CVS and Aetna intertwining.

It could be hospitals that first feel the pinch.

As an analysis in Forbes points out, much of the treatment CVS and Aetna are aiming to provide currently routes through hospitals. If those patients go away, so does the revenue. Leaders within the merging companies believe the sheer reach of established CVS locations — including pharmacies embedded in Target stores, CVS has nearly 10,000 locations nationwide — gives them a tremendous advantage.

“When you think of healthcare interventions, they have always been there, but what they lack is the element of convenience and coordination,” said Merlo. “That’s really the unmet need that we’re filling.”

Hospitals are already facing a dizzying array of challenges in the current healthcare landscape, with continued uncertainty around various governmental supports and medical reimbursements only the most visible driver of anxiety. The emergence of an entirely new business model siphoning off patients compounds those troubles.

If nothing else, the pressure to consolidate that has already resulted in approximately two-thirds of U.S. hospitals operating as part of a chain — up from around one-half of hospitals at the start of the 2000s — is only going to increase. The day after the CVS-Aetna announcement, Chicago-area health system Advocate Health Care revealed plans to merge with Wisconsin’s Aurora Health Care. The combined company will be among the ten largest nonprofit hospital systems in the nation.

Although surely unrelated to the earlier healthcare business bombshell announcement, the hospital systems forging an alliance represents a possible new necessity for organizations that want to remain viable.

“What we have been seeing across the entire healthcare spectrum is consolidation amongst many players in an effort to get bigger, in an effort to get more leverage, in an effort to negotiate better,” healthcare equity analyst Jeffrey Loo told Fast Company.

The deal between CVS and Aetna needs to be cleared by shareholders and regulators, but all parties have expressed confidence there will be little trouble in those areas. Assuming all goes smoothly, the deal is expected to close in the second half of 2018.

(Image credit: AP Photo/Gene J. Puskar, File)

Related Articles Read More >

This is a Zimmer Biomet marketing image of its Rosa robotic surgery system.
Zimmer Biomet seeks a ZBEdge for its Rosa robotic surgery
A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe